Central European Journal of Immunology

Scope & Guideline

Unveiling Insights in Central European Immunology

Introduction

Welcome to the Central European Journal of Immunology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Central European Journal of Immunology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1426-3912
PublisherTERMEDIA PUBLISHING HOUSE LTD
Support Open AccessYes
CountryPoland
TypeJournal
Convergefrom 1996 to 2024
AbbreviationCENT EUR J IMMUNOL / Central Eur. J. Immunol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKLEEBERGA 2, POZNAN 61-615, POLAND

Aims and Scopes

The Central European Journal of Immunology aims to advance the understanding of immunological processes and their applications in various fields of medicine. This journal serves as a platform for researchers to disseminate their findings on immune responses, disease mechanisms, and therapeutic interventions, focusing on both fundamental and clinical aspects of immunology.
  1. Immunological Mechanisms in Disease:
    The journal frequently publishes research on the mechanisms underlying various diseases, including cancer, autoimmune disorders, and infectious diseases, highlighting the role of the immune system in pathogenesis.
  2. Therapeutic Interventions and Biomarkers:
    A significant focus is on the development of immunotherapies and the identification of biomarkers that can aid in diagnosis, prognosis, and treatment efficacy, particularly in cancer and chronic inflammatory conditions.
  3. Translational Research:
    The journal emphasizes translational research that bridges laboratory findings with clinical applications, fostering the development of novel therapeutic strategies and diagnostic tools.
  4. Inflammation and Immune Response:
    Research related to inflammatory processes and the immune response in various conditions, including chronic diseases and infections, is a core area of focus.
  5. Innovative Methodologies:
    The journal showcases innovative methodologies in immunological research, including advanced imaging techniques, flow cytometry, and genetic profiling, to enhance the understanding of immune responses.
The Central European Journal of Immunology has seen the emergence of several new themes over the past few years, reflecting the evolving landscape of immunological research. These trends highlight areas of increasing interest and relevance to contemporary health challenges.
  1. COVID-19 and Immunological Responses:
    There has been a significant surge in research related to COVID-19, particularly focusing on immune responses to vaccination, long-term immunity, and the implications for patients with pre-existing conditions.
  2. Cancer Immunotherapy Innovations:
    Emerging themes in cancer immunotherapy, including novel approaches such as CAR T-cell therapies and immune checkpoint inhibitors, are gaining traction, reflecting the ongoing advancements in cancer treatment.
  3. Microbiome and Immune Interaction:
    Research exploring the relationship between the microbiome and immune responses is on the rise, emphasizing the importance of gut health and its implications for systemic immunity.
  4. Biomarkers for Personalized Medicine:
    The identification of biomarkers for personalized medicine in immunology is increasingly relevant, as researchers seek to tailor therapies based on individual immune profiles.
  5. Chronic Inflammation and Metabolic Disorders:
    The connection between chronic inflammation and metabolic disorders, such as obesity and diabetes, is emerging as a critical area of research, highlighting the role of the immune system in metabolic health.

Declining or Waning

While the Central European Journal of Immunology has maintained a strong focus on numerous key areas, some themes have shown a decline in prominence over recent years. This waning interest may reflect shifts in research priorities or advancements in other areas of immunology.
  1. Traditional Autoimmunity Studies:
    Research specifically focused on traditional autoimmune diseases has decreased, possibly due to a growing interest in more complex, multifactorial conditions that involve immune dysregulation.
  2. Basic Immunology without Clinical Application:
    Basic studies in immunology that do not directly translate into clinical applications are less frequently published, indicating a trend towards more clinically relevant research.
  3. In vitro Studies with Limited Clinical Relevance:
    There has been a noticeable reduction in the publication of in vitro studies that lack direct implications for patient care, as the journal increasingly favors studies with clear clinical implications.

Similar Journals

Immunity Inflammation and Disease

Bridging gaps in understanding immune responses for a healthier future.
Publisher: WILEYISSN: Frequency: 12 issues/year

Immunity, Inflammation and Disease is a premier open-access journal published by WILEY, dedicated to advancing the field of immunology and allergy. Launched in 2013, this journal has established itself as a significant platform for researchers and professionals to disseminate high-quality research findings and innovative insights that address critical issues in immune responses and inflammatory diseases. With an impact factor that reflects its growing influence and a current ranking in Q3 for Immunology and Q2 for Immunology and Allergy, this journal serves a diverse audience keen on exploring cutting-edge developments. Researchers are encouraged to submit their work to share their findings with a global reach, foster collaboration, and enhance the understanding of immune mechanisms and therapeutic strategies. Accessible since its inception, Immunity, Inflammation and Disease is committed to open science, ensuring that vital research is freely available for the advancement of knowledge within the academic community and beyond.

AIMS Allergy and Immunology

Exploring Breakthroughs in Allergy Research
Publisher: AMER INST MATHEMATICAL SCIENCES-AIMSISSN: 2575-615XFrequency: 4 issues/year

AIMS Allergy and Immunology is a prestigious open access journal dedicated to advancing knowledge in the fields of allergy and immunology. Published by the American Institute of Mathematical Sciences (AIMS), this journal provides a vibrant platform for researchers, practitioners, and scholars to share groundbreaking findings and insights. Recognized for its commitment to disseminating high-quality research since its inception in 2017, AIMS Allergy and Immunology contributes significantly to the understanding of complex immunological mechanisms and allergic responses, thus playing a pivotal role in enhancing clinical practices and therapeutic strategies. With its ISSN 2575-615X, the journal aims to facilitate a robust exchange of ideas and promote collaboration within the scientific community. Researchers and practitioners are encouraged to access the latest studies and reviews, which are all freely available online, ensuring that vital information reaches a global audience without barriers. Together, we can tackle the challenges posed by allergies and immune disorders through rigorous scientific inquiry and innovation.

JOURNAL OF IMMUNOLOGY

Championing Cutting-edge Immunological Studies
Publisher: AMER ASSOC IMMUNOLOGISTSISSN: 0022-1767Frequency: 24 issues/year

Welcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.

Immunotherapy Advances

Pioneering research that shapes the future of patient care.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 1 issue/year

Immunotherapy Advances, published by Oxford University Press, stands at the forefront of the rapidly evolving field of immunology and microbe interactions, focusing specifically on novel immunotherapeutic strategies and their clinical applications. Established in 2021, this peer-reviewed journal aims to disseminate high-quality research that contributes to the understanding and advancement of immunotherapeutic techniques, potentially transforming patient care in immunology. With a current Scopus rank of #140 out of 236 in the realm of Immunology, placing it in the 40th percentile, Immunotherapy Advances is positioned to be an integral resource for researchers, healthcare professionals, and students eager to stay updated with groundbreaking findings and methodologies. The journal is dedicated to fostering innovative discussions and collaborations, ensuring open access to vital research that influences treatment paradigms globally.

SEMINARS IN IMMUNOLOGY

Fostering Excellence in Immunological Scholarship
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 1044-5323Frequency: 6 issues/year

SEMINARS IN IMMUNOLOGY, published by Academic Press Ltd - Elsevier Science Ltd, stands as a leading journal in the field of immunology and allergy, with an impressive impact factor that reflects its significant contribution to advancing research and discourse within these vital areas of medical science. Established in 1989, this esteemed journal has garnered a reputation for disseminating high-quality, peer-reviewed articles that span a broad spectrum of immunological topics, making it an essential resource for researchers, healthcare professionals, and students alike. Currently ranked Q1 in both Immunology and Allergy categories, SEMINARS IN IMMUNOLOGY ranks 39th among 233 journals in Immunology and Allergy and 43rd among 236 in Immunology and Microbiology according to Scopus, placing it in the 83rd and 81st percentiles respectively. This underscores its pivotal role in shaping the future of immunological research and clinical practices. While the journal operates under a subscription model with no open access option, it remains committed to providing comprehensive insights and fostering scholarly collaboration within the global immunology community.

IMMUNOLOGY LETTERS

Transforming Discoveries into Clinical Applications
Publisher: ELSEVIERISSN: 0165-2478Frequency: 12 issues/year

IMMUOLOGY LETTERS, published by Elsevier, is a distinguished journal in the field of immunology, focusing on the latest advancements and findings that significantly influence immunological research and clinical applications. Established in 1979, the journal has evolved to cater to a global readership, featuring high-quality peer-reviewed articles across a diverse spectrum of topics related to immunity and allergic responses. With an impressive Q2 category ranking in both Immunology and Allergy as of 2023, it holds a strong position within the scientific community, evidenced by its commendable Scopus rankings (Rank #71/233 in Medicine - Immunology and Allergy and Rank #85/236 in Immunology and Microbiology - Immunology). While primarily subscription-based, the journal aims to foster knowledge dissemination that encourages collaboration among researchers and practitioners alike, making significant contributions to the understanding of immune mechanisms. The journal is integral for educators, students, and professionals aiming to stay abreast of current trends and breakthroughs in the immune system's intricate functions.

CRITICAL REVIEWS IN IMMUNOLOGY

Empowering Researchers with Comprehensive Reviews
Publisher: BEGELL HOUSE INCISSN: 1040-8401Frequency: 6 issues/year

CRITICAL REVIEWS IN IMMUNOLOGY, published by BEGELL HOUSE INC, is an essential journal in the field of immunology that has been contributing to the scientific discourse since 1980. With its ISSN 1040-8401 and E-ISSN 2162-6472, this journal provides a platform for critical analysis and comprehensive reviews that deepen understanding of immune responses and their implications in health and disease. Although currently categorized in the Q4 quartile for Immunology and Q3 for Immunology and Allergy, the journal's quality research and scholarly contributions are crucial for advancing knowledge within its fields—encompassing various aspects of innate and adaptive immunity. Researchers and professionals in immunology will find invaluable insights, aiding them in their quest for innovation and excellence, as the journal aims to foster interdisciplinary collaboration. While it does not operate on an open-access model, CRITICAL REVIEWS IN IMMUNOLOGY remains a significant resource for those dedicated to pushing the boundaries of immunology, with annual publications expected to last well into 2024 and beyond.

IMMUNOLOGICAL INVESTIGATIONS

Transforming Research into Impactful Immunological Insights
Publisher: TAYLOR & FRANCIS INCISSN: 0882-0139Frequency: 8 issues/year

IMMUNOLOGICAL INVESTIGATIONS, published by Taylor & Francis Inc, is a leading journal in the field of immunology and related medical sciences, with an established presence since 1972. With a focus on cutting-edge research and critical insights in immunological methods and theories, this journal serves as a pivotal platform for researchers, professionals, and students alike. Though it currently holds a Q3 ranking in Immunology and a Q2 ranking in miscellaneous medicine as of 2023, its Scopus rank of #129 out of 236 reflects its dedication to advancing the understanding of immune responses and therapies. The journal's commitment to rigorous peer review and high-quality publications enables it to remain relevant and influential in the ever-evolving landscape of immunological research. Subscription is required to access its extensive archive, which spans critical developments in the field of immunology from 1972 to 2024.

Immunopathologia Persa

Disseminating Cutting-Edge Research for All
Publisher: NIKAN RESEARCH INSTISSN: 2423-8015Frequency: 2 issues/year

Immunopathologia Persa, published by NIKAN RESEARCH INST, is a premier open-access journal specializing in the fields of immunology, hematology, and endocrinology. Since its inception in 2015, the journal has aimed to disseminate high-quality research and innovative insights critical to understanding immune responses, disease mechanisms, and therapeutic strategies. Based in Iran, the journal contributes significantly to the academic landscape, with quarterly categorizations placing it in the fourth quartile across multiple vital sectors including Endocrinology, Diabetes and Metabolism, and Immunology. It features a diverse range of articles and studies that cater to both emerging and established researchers, aiding in the advancement of knowledge and clinical practice in immunopathology. With its commitment to open access, Immunopathologia Persa ensures that cutting-edge research is readily available to all, fostering a collaborative research environment and promoting the dissemination of findings globally. Researchers, professionals, and students are encouraged to explore the contents of this journal to stay abreast of the latest developments in these critical areas of health science.

IMMUNOBIOLOGY

Advancing the frontiers of immunology and hematology.
Publisher: ELSEVIER GMBHISSN: 0171-2985Frequency: 12 issues/year

IMMUNOBIOLOGY is a prestigious academic journal published by Elsevier GmbH that significantly contributes to the fields of hematology and immunology. With its ISSN 0171-2985 and E-ISSN 1878-3279, this journal has been disseminating impactful research since 1979, positioning itself at the forefront of immunological and hematological advances. The journal holds a commendable ranking of Q2 in Hematology and Q3 in both Immunology and Immunology and Allergy, indicating its relevance and influence within the scientific community, as reflected by its Scopus rankings. Although IMMUNOBIOLOGY operates under a subscription model, it remains dedicated to expanding knowledge across disciplines, fostering innovative research, and facilitating connections among researchers, professionals, and students. Situated in Munich, Germany, this journal is continually evolving and aims to remain an essential resource for the latest discoveries and insights in the realms of immunity and blood disorders, ultimately enhancing our understanding of complex biological systems.